Francois Nader

Affiliations

  • Director at Moderna Inc. (MRNA), 2025-05-01
  • Director at Talaris Therapeutics Inc. (TALS), 2023-06-14
  • Director at Acceleron Pharma Inc (XLRN), 2021-11-22
  • Director at Alexion Pharmaceuticals Inc. (ALXN), 2021-07-23
  • Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
  • Director at Baxalta Inc (BXLT), 2016-06-07
  • Director at Trevena Inc (TRVN), 2015-05-21
  • President, Ceo And Director at Nps Pharmaceuticals Inc (NPSP), 2015-02-25
  • Director at Noven Pharmaceuticals Inc (NOVN), 2009-08-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TALS $3.72 36,500 $135,780.00 138,500 2022-07-21 Filing
TALS $3.62 52,000 $188,240.00 102,000 2022-07-20 Filing
TALS $3.52 50,000 $176,000.00 50,000 2022-07-19 Filing
TALS $3.72 36,500 $135,780.00 138,500 2022-07-21 Filing
TALS $3.62 52,000 $188,240.00 102,000 2022-07-20 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MRNA $136.10 3,196 $434,975.60 20,607 2022-05-10 Filing
NPSP $32.36 43,458 $1,406,118.36 87,820 2013-09-27 Filing
NPSP $33.60 6,497 $218,299.20 87,820 2013-09-26 Filing
NPSP $33.07 143,503 $4,745,644.21 94,317 2013-09-26 Filing
NPSP $11.68 148,367 $1,732,525.97 217,478 2013-04-10 Filing